Stockpicker Comparison Tool
Nothing here is comparable yet for these companies.
Revenue Growth
XSNX
-100.00%
VAXX
100.00%
▲ 200.00%
Gross Margin
XSNX
-30.93%
▼ -70.10%
VAXX
17500.00%
▲ 17418.00%
Free Cash Flow
XSNX
-$58.87K
▲ $2.32K
VAXX
-$12.26M
▲ $1.05M
Net Debt / EBITDA
XSNX
-4.48
▲ 63.08
VAXX
0.28
▼ -0.18
Operating Margin
XSNX
-35.83%
▼ -52.70%
VAXX
4785400.00%
▲ 4845950.00%
P/E Ratio
XSNX
2.06
▼ -0.41
VAXX
—